United Kingdom (UK) Therapeutic Vaccines Market (2025-2031) | Share, Trends, Outlook, Companies, Analysis, Value, Growth, Forecast, Competitive Landscape, Segmentation, Industry, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Therapeutic Vaccines Market - Industry Life Cycle

3.4 United Kingdom (UK) Therapeutic Vaccines Market - Porter's Five Forces

3.5 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in the UK, driving the demand for therapeutic vaccines.

4.2.2 Rising awareness about preventive healthcare measures and the benefits of therapeutic vaccines.

4.2.3 Growing government support and funding for vaccination programs in the UK.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and lengthy approval processes for therapeutic vaccines.

4.3.2 Limited availability of skilled healthcare professionals to administer vaccines effectively.

6.1 United Kingdom (UK) Therapeutic Vaccines Market, By Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F

6.1.4 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F

6.1.5 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F

6.2 United Kingdom (UK) Therapeutic Vaccines Market, By Therapeutic Vaccines

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F

6.2.3 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F

6.2.4 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F

6.2.5 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F

6.2.6 United Kingdom (UK) Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) Therapeutic Vaccines Market Export to Major Countries

7.2 United Kingdom (UK) Therapeutic Vaccines Market Imports from Major Countries

8.1 Percentage increase in public vaccination coverage rates.

8.2 Number of new therapeutic vaccine approvals by regulatory authorities in the UK.

8.3 Research and development investment in innovative vaccine technologies.

9.1 United Kingdom (UK) Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United Kingdom (UK) Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F

10.1 United Kingdom (UK) Therapeutic Vaccines Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters